Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - AutoImmune Inc. (NasdaqNM:AIMM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
1199 Madia Street
Pasadena, CA 91103
Phone: (626) 792-1235
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 43%
·Over the last 6 months:
 · 2 insider buys; 119.0K shares (1.7% of insider shares)
·Institutional: 29% (52% of float)
(19 institutions)
·Net Inst. Buying: 187.0K shares (+3.61%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
AutoImmune Inc. is a biopharmaceutical company developing a class of therapeutics for the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. Based on pre-clinical and clinical data, the Company's proprietary approach to therapy may induce tissue-specific immunosuppression without toxicity or significant side effects. All of the Company's products are based upon the principles of mucosal tolerance. When proteins are administered by a mucosal route (oral, nasal or by aerosol to the lungs), the body's natural immune system mechanisms suppress the response that would otherwise arise against a foreign substance. This immune suppression can be directed toward a specific tissue through appropriate selection and dosing of the protein in a mucosally delivered product.
More from Market Guide: Expanded Business Description

Financial Summary
AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered pharmaceutical products for the treatment of autoimmune and other cell-mediated inflammatory diseases and conditions. For the six months ended 6/30/01, revenues totaled $15 thousand, down from $4 million. Net loss totaled $192 thousand vs. an income of $3.4 million. Results reflect the absence of initial payments for certain patent rights and lower operating margins.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
Robert C. Bishop Ph.D., Chmn./Pres./CEO
Fredric G. Bader Ph.D., VP
Heather A. Ellerkamp, Treas.
Constantine Alexander, Secy.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:AIMMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Dec-2000
$1.313
Recent Price$3.05 
52-Week High
on 29-June-2001
$4.00 
Beta-0.51 
Daily Volume (3-month avg)26.9K
Daily Volume (10-day avg)27.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+22.0%
52-Week Change
relative to S&P500
+63.7%
Share-Related Items
Market Capitalization$51.6M
Shares Outstanding16.9M
Float9.60M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.56 
Earnings (ttm)-$0.02 
Earnings (mrq)-$0.00 
Sales (ttm)$0.00 
Cash (mrq)$0.57 
Valuation Ratios
Price/Book (mrq)5.39 
Price/EarningsN/A 
Price/Sales (ttm)2,053.14 
Income Statements
Sales (ttm)$25.0K
EBITDA (ttm)-$992.0K
Income available to common (ttm)-$396.0K
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-3.98%
Return on Equity (ttm)-4.06%
Financial Strength
Current Ratio (mrq)52.16 
Debt/Equity (mrq)0 
Total Cash (mrq)$9.60M
Short Interest
As of 8-Aug-2001
Shares Short20.0K
Percent of Float0.2%
Shares Short
(Prior Month)
19.0K
Short Ratio0.61 
Daily Volume33.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.